Food and Drug Administration

Cellular, Tissue and Gene Therapies Advisory Committee

March 4, 2005


Cellular Therapies for Repair and Regeneration of Joint Surfaces - Product Characterization and Testing, Dr. Malcolm Moos, Jr., MD, PhD, FDA (HTM) (PPT)

Update: Retrovirus Vector-Mediated Insertional Tumorigenesis, Dr. Carolyn Wilson, PhD (HTM) (PPT)

Use of Retroviral Vector-Mediated Gene Transfer in ADA-SCID Clinical Trials, Dr. Donald Kohn, USC Keck School of Medicine (HTM) (PPT)